SOLID TUMOR CANCER
Clinical trials for SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase study tested a new drug called DF6215, alone or with another drug (pembrolizumab), in 35 adults with advanced solid tumors that could not be removed by surgery or had spread. The main goals were to find safe doses and check for side effects. The study also looked…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New cancer drug shows promise in early safety trial
Disease control CompletedThis early-stage study tested a new drug called RP903 in 69 people with advanced solid tumors (like ovarian, breast, or cervical cancer) who had no other treatment options. The main goal was to check the drug's safety and find the right dose, not to cure the cancer. While some pa…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Generic cancer drug put to the test
Knowledge-focused CompletedThis study tested whether a new generic version of a cancer drug is absorbed by the body the same way as the existing brand-name drug. It involved 76 adults with solid tumors who took the drugs while fasting and after eating. The goal was to see if the two drug versions work simi…
Matched conditions: SOLID TUMOR CANCER
Phase: NA • Sponsor: Shandong New Time Pharmaceutical Co., LTD • Aim: Knowledge-focused
Last updated Apr 22, 2026 16:00 UTC